Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis

Authors

Institutions

Publication Details

Journal
Antimicrobial Agents and Chemotherapy
Published
2024-08-19
DOI
https://doi.org/10.1128/aac.00682-24
Citations
3
Primary Topic
Nail Diseases and Treatments
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis

Janet DuBois, Aditya Kumar Gupta, Amir Tavakkol
3 citations
Antimicrobial Agents and Chemotherapy
Nail Diseases and Treatments
1.16
article

Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis

Janet DuBois, Aditya Kumar Gupta, Amir Tavakkol
article en
3 citations

Abstract

No abstract available for this paper.
Antimicrobial Agents and ChemotherapyVol. 68(10)
University of Toronto (CA), Moberg Pharma (Sweden) (SE), Mediprobe Research (Canada) (CA), DermResearch (United States) (US)
Good health and well-being
Openalex Percentile: Top 20%
Nail Diseases and Treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.